Re: Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
(Source: BMJ Comments)
Source: BMJ Comments - December 4, 2017 Category: General Medicine Source Type: forums
Re: The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 7, 2016 Category: Journals (General) Source Type: forums
Re: Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
(Source: BMJ Comments)
Source: BMJ Comments - June 29, 2016 Category: Journals (General) Source Type: forums
Polypharmacy in atrial fibrillation: apixaban versus warfarin
(Source: BMJ Comments)
Source: BMJ Comments - June 20, 2016 Category: Journals (General) Source Type: forums
Re: Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies
(Source: BMJ Comments)
Source: BMJ Comments - February 13, 2016 Category: Journals (General) Source Type: forums
Re: Atrial fibrillation vs Anticoagulation: actual stroke risk
(Source: BMJ Comments)
Source: BMJ Comments - January 28, 2016 Category: Journals (General) Source Type: forums
Re: Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies
(Source: BMJ Comments)
Source: BMJ Comments - January 28, 2016 Category: Journals (General) Source Type: forums
Des Spence proved right Re: 'Bad medicine: atrial fibrillation'
(Source: BMJ Comments)
Source: BMJ Comments - November 10, 2015 Category: Journals (General) Source Type: forums
NOAC`s in tripletherapy
New knowledge to low dosed NOAC`s in triple therapy according to european guidelines and the following article: "Comparartive efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies", published from Dr. Morimoto T, et al. in the Journal of Cardiology in July, 7 of 2015 . There are statistical significant fewer major bleedings under Edoxaban 30 mg than under Dabigatran 110 mg while both medicines are statistically equal in efficacy. Under Rivaroxaban 15 mg there are statistically significant fewer strokes...
Source: Doc2Doc BMJ Cardiology - November 1, 2015 Category: Cardiology Authors: Mr.Study Source Type: forums
Re: Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study
(Source: BMJ Comments)
Source: BMJ Comments - October 15, 2015 Category: Journals (General) Source Type: forums
A Surgeons Dilemma. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study
(Source: BMJ Comments)
Source: BMJ Comments - August 12, 2015 Category: Journals (General) Source Type: forums
Atrial Fibrillation
Forum: Health
Posted By: Anonymous
Post Time: 15-07-2015 at 21:21 (Source: The Student Room)
Source: The Student Room - July 15, 2015 Category: Universities & Medical Training Source Type: forums
Clinical question of the week: Do novel oral anticoagulants (NOAC) need monitoring just like warfarin?
In the management of long term conditions, drug adherence and compliance remains an important problem. The cardiology community has responded positively to the introduction of novel oral anticoagulants (NOAC) as, in contrast to warfarin, NOAC obviates the need for regular monitoring. Is this too good to be true?
A study published in JAMA this week concluded that, among nonvalvular atrial fibrillation patients treated with NOAC, there is wide variability in patient medication adherence. Moreover, there is data to suggest that lower adherence with NOAC is associated with poorer outcomes and that warfarin style monitoring m...
Source: Doc2Doc BMJ Cardiology - April 20, 2015 Category: Cardiology Authors: Heart Matters Source Type: forums
